Non‐vertebral fractures · adults with cystic fibrosis who have not had a lung transplant
1 finding from 1 review
BMD: % change in BMD at the lumbar spine · adults with cystic fibrosis who have not had a lung transplant
1 finding from 1 review
BMD: % change in BMD at the hip or femur · adults with cystic fibrosis who have not had a lung transplant
1 finding from 1 review
QoL · adults with cystic fibrosis who have not had a lung transplant
1 finding from 1 review
Adverse events: bone pain (all routes of bisphosphonate administration) · adults with cystic fibrosis who have not had a lung transplant
1 finding from 1 review
New vertebral fractures · children with cystic fibrosis who have not had a lung transplant
Bisphosphonates showed no clear difference in new vertebral fractures compared with placebo (low certainty).
1 finding from 1 review
Non‐vertebral fractures · children with cystic fibrosis who have not had a lung transplant
Bisphosphonates showed no clear difference in new non‐vertebral fractures compared with placebo (low certainty).
1 finding from 1 review
BMD: % change in BMD at the lumbar spine · children with cystic fibrosis who have not had a lung transplant
1 finding from 1 review
FEV1 (% predicted): mean change from baseline · adults and children with cystic fibrosis
1 finding from 1 review
FEF25–75: rate of decline in FEF25–75 · adults and children with cystic fibrosis
1 finding from 1 review
Time to first exacerbation requiring intravenous antibiotics · adults and children with cystic fibrosis
1 finding from 1 review
QoL · adults and children with cystic fibrosis
1 finding from 1 review
Adherence to therapy and individual preference · adults and children with cystic fibrosis
1 finding from 1 review
Mucus weight · adults and children with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Annual rate of change in % predicted FEV1 All participants · adults and children with cystic fibrosis
It is very uncertain whether CCPT changes FEV1: annual decline in FEV1 % predicted compared with ACBT (very low certainty).
1 finding from 1 review
Annual rate of change in % predicted FVC Subgroup: Under 13 years of age · adults and children with cystic fibrosis
It is very uncertain whether CCPT changes FVC: annual decline in FVC % predicted compared with ACBT (very low certainty).
1 finding from 1 review
FEF25–75: annual decline in FEF25–75 % predicted · adults and children with cystic fibrosis
It is very uncertain whether CCPT changes FEF25–75: annual decline in FEF25–75 % predicted compared with ACBT (very low certainty).
1 finding from 1 review
Respiratory exacerbations: time to first exacerbation · adults and children with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
QoL · adults and children with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
FVC (% predicted) Change from baseline · adults and children with cystic fibrosis
1 finding from 1 review